|1.||Lillehoj, Hyun S: 4 articles (06/2012 - 09/2010)|
|2.||Yancey, Robert J: 4 articles (06/2012 - 09/2010)|
|3.||Dominowski, Paul: 4 articles (03/2012 - 09/2010)|
|4.||Lillehoj, Erik P: 3 articles (06/2012 - 11/2010)|
|5.||Jang, Seung I: 3 articles (06/2012 - 09/2010)|
|6.||Hook, Sarah: 2 articles (08/2015 - 07/2006)|
|7.||Mulcahy, G: 2 articles (05/2013 - 01/2009)|
|8.||Kim, Duk Kyung: 2 articles (06/2012 - 03/2012)|
|9.||Lee, Sung Hyen: 2 articles (06/2012 - 03/2012)|
|10.||Lee, Sung-Hyen: 2 articles (11/2010 - 09/2010)|
05/01/2009 - "In conclusion, these data demonstrate that although recombinant SsEno formulated with Quil A triggers a strong antibody response, it does not confer effective protection against infection with S. "
02/01/2003 - "Solubilised inclusion bodies are injected, together with Quil A, subcutaneously on two occasions 1 month or more apart, and induce protection against infection which lasts for at least 12 months. "
03/01/2015 - "with activation-associated secreted protein and Quil A adjuvant or with adjuvant alone, and subsequently challenged with a trickle infection of 25,000 infective larvae in total over 25 days. "
01/01/2009 - "The effect of Quil A adjuvant on the course of experimental Fasciola hepatica infection in sheep."
08/01/2007 - "These data demonstrate that recombinant Sao formulated with Quil A triggers strong opsonizing antibody responses which confer efficient immunity against challenge infection with heterologous S. "
09/07/2010 - "The effects of a novel adjuvant composed of Quil A, cholesterol, dimethyl dioctadecyl ammonium bromide, and Carbopol (QCDC) on protective immunity against avian coccidiosis following immunization with an Eimeria recombinant protein were determined. "
11/16/2010 - "Our previous study demonstrated that chickens immunized subcutaneously with an Eimeria recombinant profilin protein vaccine emulsified in a Quil A/cholesterol/DDA/Carbopol (QCDC) adjuvant developed partial protection against experimental avian coccidiosis compared with animals immunized with profilin alone. "
03/01/2012 - "This study investigated the ability of two novel adjuvant formulations, QCDC (Quil A/cholesterol/DDA/ Carbopol) and QCDCR (QCDC/Bay R1005), in combination with a recombinant profilin vaccine, to modulate host protective immunity and to alter gene expression during experimental avian coccidiosis. "
06/01/2012 - "The effects against avian coccidiosis of two novel adjuvants, Quil A/cholesterol/dimethyl dioctadecyl ammonium bromide/Carbopol (QCDC) and QCDC/Bay R1005 (R)/cytosine-phosphate-guanosine (CpG) oligodeoxynucleotides (CpG ODN [T]) (QCDCRT) emulsified with profilin, a conserved Eimeria recombinant protein, were determined in broiler chickens. "
06/30/2007 - "Immunization with rSAG3 or rSAG3/Quil A resulted in significantly more survival days and fewer brain cysts after challenge with T. "
05/25/2012 - "The results of this study suggest that rhoptry proteins plus Quil-A stimulated humoral, local, and systemic immune responses, which were able to partially protect the brain from cyst formation."
11/15/1991 - "This protein, when administered to outbred mice in the presence of the saponin Quil A, is able to induce almost 100% protection against acute infection without evidence of intracerebral cyst development. "
|4.||Human Influenza (Influenza)
10/01/1996 - "A challenge study was conducted to evaluate the safety and efficacy of an inactivated influenza H3N2 virus vaccine combined with Quil A/Alhydrogel mixture under controlled conditions in piglets. "
04/30/2012 - "We found, after vaccinating mice, that anti-influenza IgG antibody and haemagglutinin inhibition assay titre response induced by the Nanopatch (with delivered dose of 6.5ng of vaccine and 1.4μg of Quil-A) were equivalent to that of the conventional intramuscular injection using needle and syringe (6000ng of vaccine injected without adjuvant). "
|4.||bis(p-chlorophenyl)acetic acid (DDA)
|5.||Aluminum Hydroxide (Algeldrate)
|9.||Proteins (Proteins, Gene)
|10.||Sodium Chloride (Saline Solution)